The primary mechanism by which nicotine exerts its tumor promoting effects is through the binding to and activation of nicotinic acetylcholine receptors (nAChRs) [21,22,23] and to some extent β-Adrenergic receptors (β-ARs) [21,24]. The gene discussed is CTBP1; the disease is neoplasm.